It seems there was an error, as the content you provided is marked as "undefined." Please provide specific content for summarization.
AZN has been in the news recently: AstraZeneca PLC's stock experienced a 15% decline due to an investigation in China regarding alleged drug import violations and subsequent class action lawsuits in the U.S. Meanwhile, Innate Pharma SA is pursuing growth through its ANKET® platform and antibody-drug conjugate (ADC) programs to improve immunotherapy options for oncology and autoimmune diseases.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
